BCL2A1 and non-small cell lung carcinoma: It is possible that Bfl-1, a direct target of NF--κB, might function as an important and sensitive anti-apoptotic Bcl-2 family protein reflecting the alteration of NF--κB activity in NSCLC cells, particularly in terms of response to gemcitabine.